ArticleFASEB bioAdvances2019

New technologies to introduce a catalytic function into antibodies: A unique human catalytic antibody light chain showing degradation of β-amyloid molecule along with the peptidase activity.

Emi Hifumi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.